CCL24 was reported to be significantly increased after symptomatic intracranial hemorrhage following ischemic stroke, a rare but severe complication of intravenous thrombolysis, suggesting its role as a potential biomarker for hemorrhagic transformation [13]. This evidence concerns the gene CCL24 and ischemic stroke.